CompuGroup Net Receivables vs Common Stock Shares Outstanding Analysis

0MSD Stock

15.95 0.28 1.79%

CompuGroup Medical financial indicator trend analysis is way more than just evaluating CompuGroup Medical prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CompuGroup Medical is a good investment. Please check the relationship between CompuGroup Medical Net Receivables and its Common Stock Shares Outstanding accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CompuGroup Medical AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Net Receivables vs Common Stock Shares Outstanding

Net Receivables vs Common Stock Shares Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CompuGroup Medical Net Receivables account and Common Stock Shares Outstanding. At this time, the significance of the direction appears to have weak relationship.

The correlation between CompuGroup Medical's Net Receivables and Common Stock Shares Outstanding is 0.34. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Common Stock Shares Outstanding in the same time period over historical financial statements of CompuGroup Medical AG, assuming nothing else is changed. The correlation between historical values of CompuGroup Medical's Net Receivables and Common Stock Shares Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of CompuGroup Medical AG are associated (or correlated) with its Common Stock Shares Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Shares Outstanding has no effect on the direction of Net Receivables i.e., CompuGroup Medical's Net Receivables and Common Stock Shares Outstanding go up and down completely randomly.

Correlation Coefficient

0.34

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Net Receivables

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Most indicators from CompuGroup Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CompuGroup Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CompuGroup Medical AG. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to gain to about 47.5 M in 2024, whereas Tax Provision is likely to drop slightly above 39.6 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	5.4M	9.1M	24.3M	25.5M
Depreciation And Amortization	110.7M	112.3M	115.8M	121.6M

Interest Expense Depreciation And Amortization

CompuGroup Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Other Assets	Short Term Debt	Short Long Term Debt Total	Current Deferred Revenue	Short Term Investments	Non Current Liabilities Total
Total Assets		0.59	0.97	0.88	0.97	0.96	0.86	0.93	1.0	0.74	0.93	0.66	0.72	0.79	0.51	0.07	0.99	0.99	0.6	0.97	0.35	0.57	0.98	0.62	-0.24	0.98
Other Current Liab	0.59		0.6	0.79	0.57	0.61	0.85	0.43	0.6	0.44	0.43	0.5	0.83	0.37	0.18	-0.16	0.59	0.55	0.93	0.51	0.35	0.22	0.61	0.84	-0.26	0.65
Total Current Liabilities	0.97	0.6		0.85	0.96	0.97	0.85	0.93	0.97	0.65	0.93	0.69	0.76	0.76	0.42	0.01	0.98	0.96	0.62	0.94	0.44	0.71	0.97	0.64	-0.17	0.97
Total Stockholder Equity	0.88	0.79	0.85		0.83	0.8	0.99	0.85	0.88	0.66	0.84	0.49	0.9	0.66	0.52	0.12	0.85	0.87	0.67	0.85	0.22	0.5	0.86	0.77	-0.33	0.85
Property Plant And Equipment Net	0.97	0.57	0.96	0.83		0.96	0.83	0.89	0.97	0.67	0.89	0.66	0.68	0.87	0.48	0.05	0.97	0.97	0.61	0.94	0.39	0.59	0.97	0.62	-0.21	0.97
Net Debt	0.96	0.61	0.97	0.8	0.96		0.8	0.86	0.96	0.65	0.86	0.76	0.69	0.78	0.39	-0.06	0.98	0.96	0.68	0.92	0.45	0.57	0.98	0.62	-0.17	0.99
Retained Earnings	0.86	0.85	0.85	0.99	0.83	0.8		0.81	0.87	0.62	0.81	0.49	0.93	0.64	0.47	0.08	0.84	0.84	0.74	0.81	0.29	0.51	0.85	0.83	-0.3	0.85
Cash	0.93	0.43	0.93	0.85	0.89	0.86	0.81		0.93	0.67	1.0	0.54	0.68	0.73	0.5	0.09	0.92	0.93	0.38	0.94	0.3	0.75	0.92	0.56	-0.25	0.89
Non Current Assets Total	1.0	0.6	0.97	0.88	0.97	0.96	0.87	0.93		0.74	0.93	0.65	0.72	0.77	0.51	0.08	0.99	0.99	0.61	0.96	0.35	0.56	0.98	0.63	-0.23	0.98
Non Currrent Assets Other	0.74	0.44	0.65	0.66	0.67	0.65	0.62	0.67	0.74		0.67	0.58	0.36	0.62	0.24	-0.09	0.72	0.73	0.34	0.76	0.28	0.19	0.72	0.25	-0.11	0.71
Cash And Short Term Investments	0.93	0.43	0.93	0.84	0.89	0.86	0.81	1.0	0.93	0.67		0.53	0.68	0.73	0.49	0.1	0.92	0.93	0.38	0.93	0.31	0.75	0.92	0.56	-0.22	0.89
Net Receivables	0.66	0.5	0.69	0.49	0.66	0.76	0.49	0.54	0.65	0.58	0.53		0.34	0.59	-0.11	-0.63	0.73	0.7	0.54	0.72	0.57	0.32	0.74	0.34	-0.32	0.74
Common Stock Shares Outstanding	0.72	0.83	0.76	0.9	0.68	0.69	0.93	0.68	0.72	0.36	0.68	0.34		0.47	0.44	0.16	0.69	0.69	0.75	0.65	0.25	0.54	0.69	0.81	-0.17	0.72
Inventory	0.79	0.37	0.76	0.66	0.87	0.78	0.64	0.73	0.77	0.62	0.73	0.59	0.47		0.32	-0.04	0.81	0.84	0.34	0.84	0.41	0.42	0.8	0.34	-0.29	0.8
Other Current Assets	0.51	0.18	0.42	0.52	0.48	0.39	0.47	0.5	0.51	0.24	0.49	-0.11	0.44	0.32		0.67	0.44	0.49	0.16	0.43	-0.41	0.28	0.43	0.35	-0.13	0.43
Other Stockholder Equity	0.07	-0.16	0.01	0.12	0.05	-0.06	0.08	0.09	0.08	-0.09	0.1	-0.63	0.16	-0.04	0.67		-0.02	0.03	-0.14	-0.04	-0.49	0.04	-0.06	0.07	0.36	-0.04
Total Liab	0.99	0.59	0.98	0.85	0.97	0.98	0.84	0.92	0.99	0.72	0.92	0.73	0.69	0.81	0.44	-0.02		0.99	0.62	0.96	0.42	0.59	1.0	0.61	-0.23	0.99
Total Current Assets	0.99	0.55	0.96	0.87	0.97	0.96	0.84	0.93	0.99	0.73	0.93	0.7	0.69	0.84	0.49	0.03	0.99		0.56	0.98	0.34	0.56	0.98	0.57	-0.28	0.98
Common Stock	0.6	0.93	0.62	0.67	0.61	0.68	0.74	0.38	0.61	0.34	0.38	0.54	0.75	0.34	0.16	-0.14	0.62	0.56		0.47	0.38	0.2	0.62	0.8	-0.13	0.67
Accounts Payable	0.97	0.51	0.94	0.85	0.94	0.92	0.81	0.94	0.96	0.76	0.93	0.72	0.65	0.84	0.43	-0.04	0.96	0.98	0.47		0.32	0.57	0.96	0.5	-0.33	0.95
Other Assets	0.35	0.35	0.44	0.22	0.39	0.45	0.29	0.3	0.35	0.28	0.31	0.57	0.25	0.41	-0.41	-0.49	0.42	0.34	0.38	0.32		0.3	0.41	0.24	0.1	0.42
Short Term Debt	0.57	0.22	0.71	0.5	0.59	0.57	0.51	0.75	0.56	0.19	0.75	0.32	0.54	0.42	0.28	0.04	0.59	0.56	0.2	0.57	0.3		0.59	0.51	-0.01	0.55
Short Long Term Debt Total	0.98	0.61	0.97	0.86	0.97	0.98	0.85	0.92	0.98	0.72	0.92	0.74	0.69	0.8	0.43	-0.06	1.0	0.98	0.62	0.96	0.41	0.59		0.64	-0.25	0.99
Current Deferred Revenue	0.62	0.84	0.64	0.77	0.62	0.62	0.83	0.56	0.63	0.25	0.56	0.34	0.81	0.34	0.35	0.07	0.61	0.57	0.8	0.5	0.24	0.51	0.64		-0.2	0.64
Short Term Investments	-0.24	-0.26	-0.17	-0.33	-0.21	-0.17	-0.3	-0.25	-0.23	-0.11	-0.22	-0.32	-0.17	-0.29	-0.13	0.36	-0.23	-0.28	-0.13	-0.33	0.1	-0.01	-0.25	-0.2		-0.23
Non Current Liabilities Total	0.98	0.65	0.97	0.85	0.97	0.99	0.85	0.89	0.98	0.71	0.89	0.74	0.72	0.8	0.43	-0.04	0.99	0.98	0.67	0.95	0.42	0.55	0.99	0.64	-0.23

Click cells to compare fundamentals

CompuGroup Medical Account Relationship Matchups

CompuGroup Medical fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.1B	1.6B	1.8B	1.9B	1.9B	988.6M
Other Current Liab	61.2M	71.5M	73.5M	89.6M	169.4M	177.9M
Total Current Liabilities	236.3M	290.5M	398.3M	375.5M	346.8M	220.4M
Total Stockholder Equity	259.1M	638.7M	612.1M	672.4M	667.7M	701.1M
Property Plant And Equipment Net	131.3M	136.3M	158M	160.9M	165.7M	86.1M
Net Debt	467.0M	479.9M	634.0M	696.0M	702.5M	355.9M
Retained Earnings	221.5M	273.1M	310.7M	611.3M	702.9M	738.1M
Cash	43.8M	74.6M	107.3M	90.5M	64.5M	42.4M
Non Current Assets Total	832.9M	1.3B	1.4B	1.5B	1.5B	787.0M
Non Currrent Assets Other	24.5M	25.3M	27.4M	56.3M	44.2M	22.7M
Cash And Short Term Investments	44.7M	75.6M	107.6M	91.0M	64.5M	43.1M
Net Receivables	119.9M	(1K)	182.6M	221.9M	211.1M	107.0M
Common Stock Shares Outstanding	49.4M	53.7M	53.0M	52.3M	52.5M	55.5M
Liabilities And Stockholders Equity	1.1B	1.6B	1.8B	1.9B	1.9B	988.6M
Inventory	27.5M	18.2M	20.6M	29.4M	18.9M	11.5M
Other Current Assets	39.1M	214.3M	60.0M	78.9M	75.3M	46.9M
Other Stockholder Equity	(86.3M)	531.2M	(98.8M)	(105.2M)	(94.7M)	(90.0M)
Total Liab	805.9M	926.8M	1.2B	1.3B	1.2B	665.6M
Total Current Assets	232.9M	308.1M	370.8M	420.8M	369.8M	201.6M
Accounts Payable	47.1M	64.5M	93.2M	110.6M	82.3M	44.0M
Short Term Debt	57.9M	56.3M	115.7M	53.3M	25.9M	49.4M
Short Long Term Debt Total	510.8M	554.5M	741.3M	786.5M	766.9M	448.1M
Current Deferred Revenue	118.0M	154.1M	177.6M	69.0M	220.1M	231.1M
Short Term Investments	944K	1.0M	340K	551K	82K	77.9K
Non Current Liabilities Total	569.6M	636.3M	780.2M	895.1M	883.8M	498.0M
Intangible Assets	337.4M	545.7M	625.9M	654.7M	625.8M	419.2M
Accumulated Other Comprehensive Income	(33.1M)	53.7M	(45.1M)	(51.5M)	719.1M	755.1M
Good Will	330.9M	542.4M	588.4M	639.2M	684.1M	414.6M
Long Term Debt	318.1M	302.6M	424.5M	470.2M	540.7M	402.9M
Property Plant Equipment	131.3M	136.3M	158M	160.9M	185.0M	129.9M
Other Liab	116.7M	138.1M	154.6M	162.0M	186.3M	134.3M
Net Tangible Assets	(407.9M)	(447.1M)	(599.3M)	(618.4M)	(556.6M)	(584.4M)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for CompuGroup Stock Analysis

When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CompuGroup Net Receivables vs Common Stock Shares Outstanding Analysis

Net Receivables vs Common Stock Shares Outstanding

Net Receivables vs Common Stock Shares Outstanding Correlation Analysis

Correlation Coefficient

Net Receivables

Common Stock Shares Outstanding

CompuGroup Medical fundamental ratios Correlations

CompuGroup Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

CompuGroup Medical fundamental ratios Accounts

Also Currently Popular

Additional Tools for CompuGroup Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Short Long Term Debt Total	+ 1.0	Total Liab
Total Liab	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Stockholder Equity

Other Stockholder Equity	- 0.63	Net Receivables
Other Assets	- 0.49	Other Stockholder Equity
Other Assets	- 0.41	Other Current Assets
Short Term Investments	- 0.33	Accounts Payable
Short Term Investments	- 0.33	Total Stockholder Equity
Short Term Investments	- 0.32	Net Receivables